Sleepiz AG recently raised 1 Mio CHF on swiss “Die Höhle der Löwen”.
Sleep loss and sleep disorders are among the most common yet frequently overlooked and readily treatable health problems. Diagnosing sleep disorders today requires a patient to spend the night at a hospital while attached to lots of cables and being monitored by a technician. This is costly, consumes the time of medical professionals, and requires patients to sleep in an unfamiliar place, rather than their own bed, where their sleep will be more natural and typical.
Addressing this issue, Sleepiz developed a unique solution that enables the patient’s sleep to be monitored wirelessly at home, using very high-frequency technology and artificial intelligence to interpret sleep patterns. With wireless signals, Sleepiz’ device measures vital signs without touching the patient – enabling non-contact home diagnosis of sleep apnoea and other sleeping disorders.
“Sleepiz pursues a compelling vision of making vital sign monitoring touchless, which is a paradigm shift in the industry and paves the way for a new future of healthcare.” –Steffen Wagner, co-CEO of Verve Ventures
On “Die Höhle der Löwen” (english: “Shark Tank”), company founders compete for the investment capital they need for their business idea. In the process, successful investors, the so-called “lions,” will evaluate the ideas and decide whether they will support the founders with their investments and professional knowledge. In the first episode of season 3 on swiss channel 3+, the start-up’s captivating presentation convinced no less than four lions – Anja Graf, Bettina Hein, Lukas Speiser and Roland Brack – to invest 200.000 CHF each. After the show ended, Jürg Schwarzenbach joined the investors, raising the total amount to 1 Million CHF.
Sleepiz, a spin-off of ETH Zurich, was a previous winner of the EIT Health Headstart 2019 and the European Health Catapult 2019, offering the first medical-grade and contactless home-based sleep monitor for sleep diagnostics of the future.
Prior to the current investment, Sleepiz has already raised a pre-Seed round of approximately €278K and a Seed round of approximately €959K, which contributed to the introduction of Sleepiz One. Moreover, Sleepiz has obtained non-dilutive funding of approximately €2.77M from Innosuisse, Eurostar, H2020, EIT Health (Bridgehead 2019), Volkswirtschaftsstiftung, DeVigier, and numerous additional awards. Through the EU’s HORIZON 2020 EUROSTAR grant Sleepiz received $500k in funding earlier this year to enable the future of sleep diagnostics.
Congratulations to the team!